Rise in Ageing Population Followed By Need of Personal Care to Drive Precision Medicine Market in the Asia-Pacific Region: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Precision medicine is an evolving methodology to treat &inhibit the disease. It takes inputs based on individual inconsistency including genes, lifestyle, and environment. It also depends on the patient’s capacity of reacting to the disease, which supports doctors &researchers to start up the treatment. The medicines include system biology & panomics to govern the reason for an individual patient’s disease at the molecular level. It offers benefits for instance efficient treatment adapted to the patient’s need and type of the disease. Moreover, it can also reduce cost and helps in decreasing continual administration of drugs. According to study, “Asia-Pacific Precision Medicine Market (2018-2023)” some of the major companies that are currently working in the Asia-Pacific precision medicine market are Johnston & Johnson, Covance, Biocrates Life Sciences AG, Intomics A/S, Abbott Laboratories, Randox Laboratories, Roche, GlaxoSmithKline (GSK), Novartis AG,FerrerInCode, TepnelPharma Services, Nanostring Technologies, Medtronic, Silicon Biosystems, GE Healthcare, Eagle Genomics Ltd., Almac Group, Qiagen NV, Pfizer Inc., Quest Diagnostics Inc.,Teva Pharmaceuticals Limited. These key players have opposed each other to identify new intensive treatments opportunities for the welfare of patients. Based on the application, the precision medicine market is segmented by therapeutics and diagnostics precision medicines. Therapeutic precision medicine market is sub-segmented into medical devices & pharmaceuticals. Pharmaceuticals medicine market is defined by respiratory diseases, CNS diseases, genetic orders, oncology, skin diseases, immunology, and other diseases & disorders. In addition, diagnostics application involved many tests such as esoteric tests, direct to consumer tests and genetic tests etc. Moreover, on the based on end-user, the market is segmented into clinical labs, home cares, hospitals, and others. The market of Asia-Pacific precision medicine is majorly driven by increasing adoption of gene therapy followed by increasing advancements in the research, rising aging population, raising the rate of chronic diseases, favorable government initiatives, rising healthcare expenditure, increasing collaborations & partnerships between companies, introduction of next-generation sequencing, growing investments in research &development and higher incidence of the cancer. In Asia-pacific, the countries such as Indonesia & India have limited adoption of automated health records because of absence of appropriate healthcare statistics systems. These things have important modules of precision medicine to apprehension animated patient data. Additionally, the other challenges such as stringent government standards on approving new medicines, the adoption of artificial intelligence tools (WuxiNextCode&N-of-One), and the high cost of devices of high-end genomic technologies. China holds the largest market share of the precision medicines due to the elderly population and rise in chronic diseases. Recently, the China Precision Medicine Initiative launched by China. The main aim of the initiative is to develop the innovative progressive in precision therapies. The other key country Japan is expected to hold a significant share due to the o large aging population & increasing industrial advancement. In 2018, the value of the Asia-Pacific precision medicine market was US$ 11.0 billion. It is expected that market to reach US$ 20.9 billion, at a CAGR of 16.6%, by 2023. In the upcoming years, it is predicted that the market to grow primarily owing to the favorable compensation policies aiding businesses across borders. To know more, click on the link below:- https://www.kenresearch.com/healthcare/medical-devices/asia-pacific-precision/172436-91.html Related Reports:- https://www.kenresearch.com/healthcare/medical-devices/north-america-precision/172432-91.html https://www.kenresearch.com/healthcare/medical-devices/europe-precision-medicine/172435-91.html Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications Sales@kenresearch.com +91-9015378249 Post Views: 1 Tags: Asia-Pacific Precision Medicine Industry Research Report, Asia-Pacific Precision medicine Market Analysis, Asia-Pacific Precision Medicine Market Future outlook, Asia-Pacific Precision Medicine Market Growth Forecast, Asia-Pacific Precision Medicine Market Major Players, Asia-Pacific Precision Medicine Market Overview, Asia-Pacific Precision Medicine Market Research Report, Asia-Pacific Precision Medicine Market Segmentation, Asia-Pacific Precision Medicine Market Share, Báo cáo nghiên cứu thị trường y học chính xác châu Á-Thái Bình Dương, Precision Medicine Industry in Asia-Pacific, Precision Medicine Market in Asia-Pacific, Scope of Precision Medicine Market in Asia-Pacific, アジア太平洋地域の精密医療市場調査レポート, 亚太精准医药市场研究报告, 아시아 태평양 정밀 의학 시장 조사 보고서